JPRN-jRCT2080221510未知2 期
Clinical pharmacology study of FYX-051 for subjects with renal insufficiency
适应症
试验速览
- 阶段
- 2 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 64age old（—）
- 性别
- Male
入选标准
- •Subjects belonging to the following criteria of inulin clearance (Cin)
- •Normal group (Cin: 90mL/min/1.73m^2 or more),
- •Slightly-decreased group (Cin: 60mL/min/1.73m^2 or more, 90mL/min/1.73m^2 under),
- •Moderately-decreased group (Cin: 30mL/min/1.73m^2 or more, 60mL/min/1.73m^2 under),
排除标准
- •Subject with disease of gut, heart and liver
- •Subject with surgical history of apparatus digestorius (gut, liver, gallbladder, bile duct, pancreas and so on) and kidney
- •Subject with AST(GOT) or ALT(GPT) of 100IU/L or more
研究者
相似试验
未知
3 期
ong-Term Safety and Efficacy of FYX-051 in Patients with Hyperuricemia (with or without Gout)Hyperuricemia and GoutJPRN-jRCT2080221035SANWA KAGAKU KENKYUSHO Co., Ltd.
未知
3 期
ong-Term Safety and Efficacy of FYX-051 in Patients with Hyperuricemia (with or without Gout)JPRN-jRCT2080221050Fuji Yakuhin Co., Ltd.
未知
2 期
Exploratory study of FYX-051 in Patients with Hyperuricemia (with or without Gout)Hyperuricemia and GoutJPRN-jRCT2080221278Fuji Yakuhin Co., Ltd.
已完成
1 期
Clinical Pharmacology of FYU-981 (Subjects With Hepatic Insufficiency)HealthyHepatic InsufficiencyNCT03306667Mochida Pharmaceutical Company, Ltd.24
已完成
1 期
Clinical Pharmacology of FYU-981 (Subjects With Renal Insufficiency)HealthyRenal InsufficiencyNCT02347046Fuji Yakuhin Co., Ltd.18